Hilleman Eyes Bangladesh Approval Of Novel, Cheaper Cholera Vaccine This Year

Indian vaccine research organization Hilleman Laboratories says it is hoping to get its "new design", cheaper cholera vaccine licensed in Bangladesh this year and that the next step will be to seek to make it available to UN agencies amid remaining global inoculation need.

Vial Separation Turntable
HILLEMAN AIMS FOR NEW VACCINE APPROVAL • Source: Shutterstock

More from Focus On Asia

More from Scrip